Navigation Links
ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
Date:12/5/2007

ATLANTA, Dec. 5 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) will host its annual high school student symposium at the Georgia World Congress Center on Friday, December 7, 2007, beginning at 8:00 a.m. EST. The symposium, which encourages an interest in hematology, the biological sciences, and medical research, is held in conjunction with the Society's 49th Annual Meeting. This year, students will have the opportunity to explore research on sickle cell disease, an inherited blood disorder, which distorts the shape of red blood cells, causing severe pain.

"The symposium is always a great opportunity to get students interested in hematology and biomedical science in general," said Scott D. Gitlin, MD, Chair of ASH's Committee on Training Programs, which helped organize the event. "Focusing on a well-known disorder like sickle cell disease is an excellent way to introduce students to this exciting specialty."

Students from five local high schools, including Carver School of Health Science and Research, Mays High School, South Atlanta High School of Health and Medical Science, Therrell High School of Engineering, Math, and Sciences, and Therrell High School of Health Science and Research, will participate in a series of activities related to sickle cell disease during the half-day symposium. Each student will receive a worksheet to gather data related to the presentations. Teachers will later use the worksheet to facilitate classroom discussions.

After a kick-off breakfast, Peter Lane, MD, from Emory University, will give a presentation focusing on the diagnosis and clinical manifestations of sickle cell disease as part of the symposium. Later in the morning, Michael Bender, MD, of the Fred Hutchinson Cancer Research Center, will give a lecture on treatment options for sickle cell disease. Students will also have an opportunity to hear real-life experiences from young people living with sickle cell disease.

In addition, ASH will sponsor a poster contest for symposium participants. Students, in teams, can conduct research on sickle cell disease and present their findings in a poster and oral presentation. ASH symposium speakers and volunteers will judge the posters, awarding the top three groups with cash prizes of $1,500, $1,000, and $750. The prize money will then go to the winning teams' science departments.

The American Society of Hematology (http://www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.


'/>"/>
SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
2. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
3. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
4. So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
5. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
6. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
7. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
8. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
9. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
10. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
11. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):